Established that GLDN functions as a surface adhesion molecule whose binding to axonal NF186 is required to initiate Na+ channel clustering at nodes of Ranvier, and that human loss-of-function disrupts this in disease.
Evidence Cell-based localization and NF186 co-interaction assays, TEM of human sciatic nerve, and exome/linkage analysis across four unrelated families
- Does not resolve the structural basis of the GLDN-NF186 interaction
- Does not define how surface localization is regulated
- Mechanism linking nodal disruption to arthrogryposis phenotype not detailed